FOLR2 and interstitial lung disease: Thus, the characterization of macrophage subpopulations, particularly of FR-β-positive macrophages, might further elucidate the mechanisms of fibrosis in ILD and identify novel macrophage- or macrophage-related therapeutic targets (15) including FR-β-targeted molecular therapies (40, 80–82).